ACRE Charter Meeting & Conference - Thursday, July 23, 2009

 Conference Background

Under mounting pressure from interest groups, the media, and select government officials, academic medical centers have begun adopting restrictive conflict of interest policies that often sever productive relationships between industry and physicians involved in clinical research and educational outreach.

Among the many proposed restrictions, bans on product-based speaking, consulting, restrictions on industry funded research and continuing medical education, are at the forefront.  The purpose of the conference is to provide a forum for researchers and educators to understand the rationale behind the proposals, to evaluate objectively whether this rationale stands up to rigorous scrutiny, and to formulate plans for addressing relevant policy going forward.

Click here for the conference flyer.

This conference is supported entirely by registration and membership donations. It is not supported by grants from  the government, insurance industry, pharmaceutical companies, or medical device manufacturers.

ACRE Charter Meeting & Conference

OPTIMIZING VALUE TO PATIENT CARE OF INDUSTRY-PHYSICIAN COLLABORATION

Date:         Thursday, July 23, 2009

Time:        10:00 AM - 4:00 PM

Location:  Bornstein Amphitheater, Brigham & Women’s Hospital

                   Boston, MA

Conference Topics

• Value and Challenges to Collaboration
• Regulatory Challenges: Massachusetts Legislation & Physician Payment Sunshine Act
• AMC Conflict of Interest Policies: National and Local Trends
• Value of Product-Based Speaking: Facts and Regulations
• Value of Certified CME: Facts and Regulations
• Value of Collaboration to Medical Training Programs & Professional Associations
• Recommendations

Meeting Agenda             

CONFERENCE WEBCAST                    Handout                       Disclosures   

List of Speakers 

Henry R. Black, MD, MA Hypertension Division, New York University Medical Center, President, American Society of Hypertension

Sarah Elisabeth Curi, JD, MPH Associate Counsel, Office of the General Counsel, Massachusetts Medical Society

Amy Farber, PhD Medical Ethicist, Founder and CEO, AM Treatment Alliance

Jeffrey S. Flier, MD Dean, Harvard Medical School, Carolyn Shields Walker Professor of Medicine

Thomas J. Fogarty, MD Director, Fogarty Institute

Rafael F. Fonseca, MD, PhD Mayo Clinic Arizona, Consultant, Professor of Medicine Deputy Director Mayo Clinic Cancer Center

Arnold I. Friede, JD Council, McDermott Will and Emery

Jeffrey R. Garber, MD, FACP, FACE Beth Israel Deaconess Medical Center; Harvard Vanguard Medical Associates, President, American Association of Clinical Endocrinologists

Bruce Gingles VP and Global Business Leader of Critical Care Division, Cook Medical Group

J Michael Gonzalez-Campoy, MD, PhD, FACE Medical Director and CEO, MNCOME, Member, AACE Board of Directors

Simon M. Helfgott, MD Associate Professor of Medicine, Harvard Medical School, Director of Education, and Fellowship Training, Division of Rheumatology, Brigham and Women's Hospital

Laurence J. Hirsch, MD Vice President, Global Medical Affairs, Diabetes Care, BD/Beckton Dickenson Medical

Barton A. Kamen, MD, PhD Chief Medical Officer, The Leukemia & Lymphoma Society

Carey D. Kimmelstiel, MD Associate Professor, Tufts University School of Medicine, Director, Adult Cardiac Catheterization Laboratory and Interventional Cardiology, Director, Clinical Cardiology

Avi B. Markowitz, MD Bill and Louise Bauer Distinguished Chair in Cancer Research, Professor and Chief, Division of Hematology/Oncology, Associate Clinical Director and Department Head of the Office of Oncology Clinical Trials, UTMB Comprehensive Cancer Center, University of Texas Medical Branch

Tracy L. Olson Senior Therapeutic Specialist Pfizer, Inc Anti-Infective Division, Patient with Multiple Sclerosis

Paul G. Richardson, MD Associate Professor of Medicine, Harvard Medical School, Clinical Director, Jerome Lipper Center for Multiple Myeloma, Dana-Farber Cancer Institute

State Representative Michael J. Rodrigues Vice Chairman, Committee on Public Service, Commonwealth of Massachusetts

Lance K. Stell, PhD Thatcher Professor of Philosophy, Director, Medical Humanities Program, Davidson College

Thomas P. Stossel, MD American Cancer Society Professor of Medicine Harvard Medical School Director, Translational Medicine Division Senior Physician, Hematology Division Brigham & Women's Hospital Senior Fellow, Manhattan Institute for Policy Research

Thomas P. Sullivan President, Rockpointe Corporation

Lawrence W. Vernaglai, JD Partner, Foley Lardner, LLP

Michael A. Weber, MD Professor of Medicine, SUNY Downstate Medical Center College of Medicine, Brooklyn, New York

Hotel Information

A small block of hotel rooms has been reserved for this conference at:

To take advantage of the $169/night conference rate you need to mention you are attending the ACRE or Association of Clinical Researchers and Educators conference.  This rate is only available until July 13.

The hotel is across the street from Bingham Women’s Hospital, the site of the conference.

Back to Top